Vaxil Bio Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was CAD 209,000 compared to CAD 291,000 a year ago. Net loss was CAD 209,000 compared to CAD 297,000 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago. For the half year, operating loss was CAD 467,000 compared to CAD 462,000 a year ago. Net loss was CAD 467,000 compared to CAD 470,000 a year ago. Basic eps - continuing operations was CAD 0 compared to basic loss per share from continuing operations of CAD 0.01 a year ago.